81 results on '"Burnouf, Thierry"'
Search Results
2. Blood–brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies
3. Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient’s safety and survival outcome:A systematic narrative appraisal of where we are now!
4. Blood transfusion in autoimmune rheumatic diseases
5. Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop
6. SARS-CoV-2 and cancer: the intriguing and informative cross-talk
7. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
8. Platelet and extracellular vesicles in COVID-19 infection and its vaccines
9. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma
10. Near-infrared-driven photoablation of lung cancer tumors utilizing biomimetic platelet-polyethyleneimine-polypyrrole drug-free nanoparticles
11. Regenerative effect of expired platelet concentrate in human therapy: An update
12. Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis
13. Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth medium supplemented with 10% human platelet lysate
14. A purified human platelet pellet lysate rich in neurotrophic factors and antioxidants repairs and protects corneal endothelial cells from oxidative stress
15. Prospective Therapeutic Applications of Platelet Extracellular Vesicles
16. Intelligent micro-/nanorobots as drug and cell carrier devices for biomedical therapeutic advancement: Promising development opportunities and translational challenges
17. Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells
18. Effect of cell culture biomaterials for completely xeno-free generation of human induced pluripotent stem cells
19. Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA)
20. Plasma fractionation in countries with limited infrastructure and low-/medium income: How to move forward?
21. Production and Quality Requirements of Human Platelet Lysate: A Position Statement from the Working Party on Cellular Therapies of the International Society of Blood Transfusion
22. Blood products: unmet needs for essential medicines
23. Viral safety of human platelet lysate for cell therapy and regenerative medicine: Moving forward, yes, but without forgetting the past
24. A bioinspired hyperthermic macrophage-based polypyrrole-polyethylenimine (Ppy-PEI) nanocomplex carrier to prevent and disrupt thrombotic fibrin clots
25. Les surnageants du concentré plaquettaire modifient l’expression de l’ARNm et des protéines des cellules endothéliales en fonction de la durée
26. Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential
27. NanoBioAnalytical characterization of extracellular vesicles in 75-nm nanofiltered human plasma for transfusion: A tool to improve transfusion safety
28. Extracellular Microvesicles as New Industrial Therapeutic Frontiers
29. New monoclonal/bi-specific antibodies: Reshaping transfusion medicine beyond replacement
30. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells
31. Fabrication of co-electrodeposition of plasma proteins/iridium oxide hybrid films
32. Nanofiltration of extracellular vesicles from human plasma & their on-chip qualification and quantification with a NanoBioAnalytical platform
33. Bitter progress in the treatment of haemophilia A in low-income countries
34. Circulatory-cell-mediated nanotherapeutic approaches in disease targeting
35. What can be learned in the snake antivenom field from the developments in human plasma derived products?
36. Comparison of three human platelet lysates used as supplements for in vitro expansion of corneal endothelium cells
37. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease
38. Red blood cell transfusion and outcome in cancer
39. The microbiome and transfusion in cancer patients
40. Platelet transfusion in thrombocytopenic cancer patients: Sometimes justified but likely insidious
41. Transfusion-related immunomodulation and cancer
42. Reflections on multiple strategies to reduce transfusion in cancer patients: A joint narrative
43. Removal process of prion and parvovirus from human platelet lysates used as clinical-grade supplement for ex vivo cell expansion
44. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry
45. Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine
46. Commentary on technical specifications and safety requirements of serum eye drops: Keeping a close eye on the content in cytokines
47. Quality, safety and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress
48. Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
49. Platelet microparticles and cancer: An intimate cross-talk
50. Blood cell-derived microparticles and nanoparticles: Multifaceted topics for research
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.